Stephan Bodis
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Achard V, Matzinger O, Peguret N, Pesce G, Putora P, Reuter C, Richetti A, Vees H, Vrieling C, Zaugg K, Zimmermann F, Zwahlen D, Tsoutsou P, Kaouthar K, Huck C, Herrmann E, Aebersold D, Allal A, Andratschke N, Baumert B, Beer K, Betz M, Breuneval T, Bodis S, De Bari B, Förster R, Franzetti-Pellanda A, Guckenberger M, Zilli T. A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives. Radiother Oncol 2020; 150:1-3.
Jun 6, 2020A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Jun 6, 2020Radiother Oncol 2020; 150:1-3
Achard Vérane, Matzinger Oscar, Peguret Nicolas, Pesce Gianfranco, Putora Paul Martin, Reuter Christiane, Richetti Antonella, Vees Hansjörg, Vrieling Conny, Zaugg Kathrin, Zimmermann Frank, Zwahlen Daniel R, Tsoutsou Pelagia, Kaouthar Khanfir, Huck Constance, Herrmann Evelyn, Aebersold Daniel M, Allal Abdelkarim S, Andratschke Nicolaus, Baumert Brigitta G, Beer Karl T, Betz Michael, Breuneval Thomas, Bodis Stephan, De Bari Berardino, Förster Robert, Franzetti-Pellanda Alessandra, Guckenberger Matthias, Zilli Thomas
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Ghadjar P, Kranzbühler H, Najafi Y, Ost P, Azinwi N, Reuter C, Bodis S, Kaouthar K, Budach V, Aebersold D, Thalmann G, Sumila M, Biaggi-Rudolf C, Stalder L, Hayoz S, Genitsch V, Zwahlen D, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A, Putora P, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
Jan 19, 2017Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Jan 19, 2017BJU Int 2017; 120:E45-E51
Ghadjar Pirus, Kranzbühler Helmut, Najafi Yousef, Ost Piet, Azinwi Ngwa C, Reuter Christiane, Bodis Stephan, Kaouthar Khanfir, Budach Volker, Aebersold Daniel M, Thalmann George N, Sumila Marcin, Biaggi-Rudolf Christine, Stalder Lukas, Hayoz Stefanie, Genitsch Vera, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Guckenberger Matthias, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Pesce G, Bernhard J, Kotrubczik N, D'Addario G, Pilop C, Weber D, Bodis S, Pless M, Mayer M, Cathomas R, Peters S, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar C, Fischer N, Anchisi S, Stupp R. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03). Eur J Cancer 2011; 48:377-84.
Nov 15, 2011Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Nov 15, 2011Eur J Cancer 2011; 48:377-84
Pesce Gianfranco A, Bernhard Jürg, Kotrubczik Nina M, D'Addario Giannicola, Pilop Christiane, Weber Damien C, Bodis Stephan, Pless Miklos, Mayer Michael, Cathomas Richard, Peters Solange, Klingbiel Dirk, Ribi Karin, Zouhair Abderahim, von Moos Roger, Schlaeppi Marc, Caspar Clemens B, Fischer Natalie, Anchisi Sandro, Stupp Roger
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes
Ribi K, Stahel R, Ris H, Stupp R, Schmid R, Betticher D, Jörger M, Bodis S, Weder W, Schuller J, Bernhard J, Swiss Group for Clinical Cancer Research SAKK. Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung cancer (Amsterdam, Netherlands) 2008; 61:398-404.
Sep 1, 2008Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes
Sep 1, 2008Lung cancer (Amsterdam, Netherlands) 2008; 61:398-404
Ribi Karin, Stahel Rolf A, Ris Hans-Beat, Stupp Roger, Schmid Ralph A, Betticher Daniel, Jörger Markus, Bodis Stephan, Weder Walter, Schuller Jan C, Bernhard Jürg, Swiss Group for Clinical Cancer Research SAKK
Management and costs of treating lung cancer patients in a university hospital
Dedes K, Szucs T, Bodis S, Jörger M, Lowy A, Russi E, Steinert H, Weder W, Stahel R. Management and costs of treating lung cancer patients in a university hospital. PharmacoEconomics 2004; 22:435-44.
Jan 1, 2004Management and costs of treating lung cancer patients in a university hospital
Jan 1, 2004PharmacoEconomics 2004; 22:435-44
Dedes Konstantin J, Szucs Thomas D, Bodis Stephan, Jörger Markus, Lowy Adam, Russi Erich W, Steinert Hans C, Weder Walter, Stahel Rolf A